35 related articles for article (PubMed ID: 29752720)
1. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating tumor lysate-reactive CD4+ T cells in melanoma patients.
Ladekarl M; Agger R; Fleischer CC; Hokland M; Hulgaard EF; Kirkin A; von der Maase H; Petersen MS; Rytter C; Zeuthen J; Gundersen HJ
Cancer Immunol Immunother; 2004 Jun; 53(6):560-6. PubMed ID: 14985861
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells.
Thomson A; Bento DFC; Scurr MJ; Smart K; Somerville MS; Keita ÅV; Gallimore A; Godkin A
Br J Cancer; 2021 Apr; 124(9):1552-1555. PubMed ID: 33674735
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.
Hillen F; Baeten CI; van de Winkel A; Creytens D; van der Schaft DW; Winnepenninckx V; Griffioen AW
Cancer Immunol Immunother; 2008 Jan; 57(1):97-106. PubMed ID: 17602225
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation.
Sims TT; El Alam MB; Karpinets TV; Dorta-Estremera S; Hegde VL; Nookala S; Yoshida-Court K; Wu X; Biegert GWG; Delgado Medrano AY; Solley T; Ahmed-Kaddar M; Chapman BV; Sastry KJ; Mezzari MP; Petrosino JF; Lin LL; Ramondetta L; Jhingran A; Schmeler KM; Ajami NJ; Wargo J; Colbert LE; Klopp AH
Commun Biol; 2021 Feb; 4(1):237. PubMed ID: 33619320
[TBL] [Abstract][Full Text] [Related]
6. Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers.
Izquierdo C; Ortiz AZ; Presa M; Malo S; Montoya A; Garabatos N; Mora C; Verdaguer J; Stratmann T
Sci Rep; 2018 May; 8(1):8106. PubMed ID: 29802270
[TBL] [Abstract][Full Text] [Related]
7. High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity.
de Vries NL; van Unen V; Ijsselsteijn ME; Abdelaal T; van der Breggen R; Farina Sarasqueta A; Mahfouz A; Peeters KCMJ; Höllt T; Lelieveldt BPF; Koning F; de Miranda NFCC
Gut; 2020 Apr; 69(4):691-703. PubMed ID: 31270164
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated fibroblasts derived exosomes induce the proliferation and cisplatin resistance in esophageal squamous cell carcinoma cells through RIG-I/IFN-β signaling.
Cui Y; Zhang S; Hu X; Gao F
Bioengineered; 2022 May; 13(5):12462-12474. PubMed ID: 35587143
[TBL] [Abstract][Full Text] [Related]
9. Impact of genetic variants in IL-2RA and IL-2RB on breast cancer risk in Chinese Han women.
He L; Zhang W; Yang S; Meng W; Dou X; Liu J; Liu Y; Li H; Jin T
Biochem Genet; 2021 Jun; 59(3):697-713. PubMed ID: 33507447
[TBL] [Abstract][Full Text] [Related]
10. Brick plots: an intuitive platform for visualizing multiparametric immunophenotyped cell clusters.
Norton SE; Leman JKH; Khong T; Spencer A; Fazekas de St Groth B; McGuire HM; Kemp RA
BMC Bioinformatics; 2020 Apr; 21(1):145. PubMed ID: 32293253
[TBL] [Abstract][Full Text] [Related]
11. Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69
Vitales-Noyola M; Oceguera-Maldonado B; Niño-Moreno P; Baltazar-Benítez N; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; González-Amaro R
Mediators Inflamm; 2017; 2017():2513829. PubMed ID: 29038617
[TBL] [Abstract][Full Text] [Related]
12. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
Qin JZ; Upadhyay V; Prabhakar B; Maker AV
J Transl Med; 2013 Mar; 11():70. PubMed ID: 23514280
[TBL] [Abstract][Full Text] [Related]
13. CD69: from activation marker to metabolic gatekeeper.
Cibrián D; Sánchez-Madrid F
Eur J Immunol; 2017 Jun; 47(6):946-953. PubMed ID: 28475283
[TBL] [Abstract][Full Text] [Related]
14. Is CD69 an effective brake to control inflammatory diseases?
González-Amaro R; Cortés JR; Sánchez-Madrid F; Martín P
Trends Mol Med; 2013 Oct; 19(10):625-32. PubMed ID: 23954168
[TBL] [Abstract][Full Text] [Related]
15. Prognostic roles for IL-2-producing and CD69
Taylor ES; McCall JL; Shen S; Girardin A; Munro FM; Black MA; Ward-Hartstonge KA; Kemp RA
Int J Cancer; 2018 Oct; 143(8):2008-2016. PubMed ID: 29752720
[TBL] [Abstract][Full Text] [Related]
16. Determination of a CD4
Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
